Microbes make, stabilize, and test drugs all inside a cell A new bacterial platform can produce millions of stabilized peptides in a single experiment, accelerating the search for therapies against hard-to-drug targets.

https://www.drugdiscoverynews.com/microbes-make-stabilize-and-test-drugs-all-inside-a-cell-17060?utm_campaign=DDN_Newsletter_Science%20Spotlight&utm_medium=email&_hsenc=p2ANqtz--HnIU43LWTvQmvUrjnwI-Jts60wFM0-Rhu70sSeiTydtR19hwi6EFPj5tR6iVGwP74EYmeJw-WZ20Flp2qw2nWY8yNSQ&_hsmi=408663516&utm_content=408663516&utm_source=hs_email Peptide therapeutics are experiencing a surge of interest, driven by significant advances, including the blockbuster success of weight loss drugs like semaglutide and tirzepatide. With more than 80 peptide drugs already on the market and hundreds more in clinical and preclinical development, the global market for peptide-based therapeutics is expected to grow to $68.83 billion by 2028.